• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症侵袭与转移。

Cancer invasion and metastasis.

作者信息

Wittekind Christian, Neid Matthias

机构信息

Institut fur Pathologie, Universitatsklinikum Leipzig, Leipzig, Deutschland.

出版信息

Oncology. 2005;69 Suppl 1:14-6. doi: 10.1159/000086626. Epub 2005 Sep 19.

DOI:10.1159/000086626
PMID:16210871
Abstract

Metastasis is the transfer of malignant tumors from one organ to a distant organ. It is the most common cause of death in cancer patients. Different molecular mechanisms enable tumor cells to infiltrate the surrounding tissue, invade blood vessels and leave the blood stream at a different site. Tumor cell interaction with extracellular matrix components and epithelial-mesenchymal transition as well as angiogenesis are important factors in invasion and metastasis. Gene expression profiles of metastatic cells in various organs are different and not every tumor cell has the capacity to metastasize. The microenvironment in the organ influences formation of metastasis. Only 1% of micrometastases progress into macrometastases.

摘要

转移是指恶性肿瘤从一个器官转移至远处器官。它是癌症患者最常见的死亡原因。不同的分子机制使肿瘤细胞能够浸润周围组织、侵入血管并在不同部位离开血流。肿瘤细胞与细胞外基质成分的相互作用、上皮-间质转化以及血管生成是侵袭和转移的重要因素。不同器官中转移细胞的基因表达谱各不相同,并非每个肿瘤细胞都有转移能力。器官中的微环境会影响转移的形成。只有1%的微转移会发展为大转移。

相似文献

1
Cancer invasion and metastasis.癌症侵袭与转移。
Oncology. 2005;69 Suppl 1:14-6. doi: 10.1159/000086626. Epub 2005 Sep 19.
2
The basement membrane matrix in malignancy.恶性肿瘤中的基底膜基质
J Pathol. 2003 Jul;200(4):465-70. doi: 10.1002/path.1396.
3
Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.前列腺癌进展的分子见解:肿瘤微环境的缺失环节
J Urol. 2005 Jan;173(1):10-20. doi: 10.1097/01.ju.0000141582.15218.10.
4
Transglutaminases: key regulators of cancer metastasis.转谷氨酰胺酶:癌症转移的关键调节因子。
Amino Acids. 2013 Jan;44(1):25-32. doi: 10.1007/s00726-012-1229-7.
5
Critical determinants of metastasis.转移的关键决定因素。
Semin Cancer Biol. 2002 Apr;12(2):89-96. doi: 10.1006/scbi.2001.0416.
6
Molecular mechanisms of cancer metastasis: tumor and host properties and the role of oncogenes and suppressor genes.癌症转移的分子机制:肿瘤与宿主特性以及癌基因和抑癌基因的作用
Curr Opin Oncol. 1991 Feb;3(1):75-92.
7
Key molecular mechanisms in lung cancer invasion and metastasis: a comprehensive review.肺癌侵袭和转移的关键分子机制:全面综述。
Crit Rev Oncol Hematol. 2013 Jul;87(1):1-11. doi: 10.1016/j.critrevonc.2012.12.007. Epub 2013 Jan 16.
8
Suppression of distant pulmonary metastasis of MDA-MB 435 human breast carcinoma established in mammary fat pads of nude mice by retroviral-mediated TIMP-2 gene transfer.通过逆转录病毒介导的TIMP-2基因转移抑制在裸鼠乳腺脂肪垫中建立的MDA-MB 435人乳腺癌的远处肺转移。
J Gene Med. 2005 Feb;7(2):145-57. doi: 10.1002/jgm.645.
9
[The metastatic cascade: angiogenesis and new concepts].[转移级联反应:血管生成与新概念]
Prog Urol. 2008 Nov;18 Suppl 7:S156-66. doi: 10.1016/S1166-7087(08)74538-X.
10
The role of the extracellular matrix in tumor cell metastasis.细胞外基质在肿瘤细胞转移中的作用。
In Vivo. 1994 Jan-Feb;8(1):49-58.

引用本文的文献

1
The Impact and Molecular Mechanisms of Exercise in Cancer Therapy.运动在癌症治疗中的影响及分子机制
Curr Issues Mol Biol. 2025 May 20;47(5):374. doi: 10.3390/cimb47050374.
2
A Network Based Model for Predicting Spatial Progression of Metastasis.一种基于网络的转移空间进展预测模型。
Bull Math Biol. 2025 Apr 9;87(5):65. doi: 10.1007/s11538-025-01441-1.
3
Low expression of PRTN3 regulates the progression of gastric cancer by inhibition of cell cycle and promotion of apoptosis.PRTN3低表达通过抑制细胞周期和促进凋亡来调控胃癌进展。
Transl Cancer Res. 2025 Feb 28;14(2):1415-1427. doi: 10.21037/tcr-2025-153. Epub 2025 Feb 26.
4
EpCAM Signaling in Oral Cancer Stem Cells: Implications for Metastasis, Tumorigenicity, and Therapeutic Strategies.口腔癌干细胞中的上皮细胞黏附分子信号传导:对转移、致瘤性及治疗策略的影响
Curr Issues Mol Biol. 2025 Feb 14;47(2):123. doi: 10.3390/cimb47020123.
5
Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors.噻唑稠合雄烯酮和炔诺酮衍生物:治疗黑色素瘤肿瘤的强效β-和γ-肌动蛋白细胞骨架抑制剂
RSC Med Chem. 2024 Dec 6. doi: 10.1039/d4md00719k.
6
Prevention of liver metastasis via the pharmacological suppression of AMIGO2 expression in tumor cells.通过药物抑制肿瘤细胞中 AMIGO2 的表达来预防肝转移。
Sci Rep. 2024 Nov 15;14(1):28183. doi: 10.1038/s41598-024-71827-z.
7
Detection, significance and potential utility of circulating tumor cells in clinical practice in breast cancer (Review).循环肿瘤细胞在乳腺癌临床实践中的检测、意义及潜在应用(综述)
Oncol Lett. 2024 Oct 17;29(1):10. doi: 10.3892/ol.2024.14756. eCollection 2025 Jan.
8
Two spurge species, Euphorbia resinifera O. Berg and Euphorbia officinarum subsp. echinus (Hook.f. & Coss.) Vindt inhibit colon cancer.两种大戟属植物,乳浆大戟和飞扬草,抑制结肠癌。
BMC Complement Med Ther. 2024 Jul 10;24(1):261. doi: 10.1186/s12906-024-04566-3.
9
A novel selenium analog of HDACi-based twin drug induces apoptosis and cell cycle arrest via CDC25A to improve prostate cancer therapy.一种新型基于 HDACi 的硒类似物双药物通过 CDC25A 诱导细胞凋亡和细胞周期停滞,改善前列腺癌治疗。
Theranostics. 2024 Jun 3;14(9):3565-3582. doi: 10.7150/thno.92119. eCollection 2024.
10
Dicerandrol C Suppresses Proliferation and Induces Apoptosis of HepG2 and Hela Cancer Cells by Inhibiting Wnt/β-Catenin Signaling Pathway.Dicerandrol C 通过抑制 Wnt/β-连环蛋白信号通路抑制 HepG2 和 Hela 癌细胞的增殖并诱导其凋亡。
Mar Drugs. 2024 Jun 14;22(6):278. doi: 10.3390/md22060278.